# Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement

> **NCT02952573** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 20 (actual)

## Conditions studied

- Multiple Myeloma
- Relapsed/Refractory

## Interventions

- **DRUG:** JNJ-42756493
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02952573
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-13
- **Primary completion:** 2018-11-13
- **Final completion:** 2018-11-13
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Low patient accrual
- **Last updated:** 2020-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952573, "Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02952573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*